Transcatheter Aortic Valve Replacement: Current Status and Future IndicationsManish Vinayak, Sahil Khera, Pier Pasquale Leone et al.|Journal of Clinical Medicine|2024Cited by 29
Treatment of Additional Vessels During Percutaneous Coronary Intervention for Unprotected Left Main Disease: Insights From a Large Prospective RegistrySean Gilhooley, Samin K. Sharma, Johny Nicolas et al.|The American Journal of Cardiology|2025Cited by 1
INFLAMMATION AND CONTRAST ASSOCIATED ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONJohny Nicolas, Roxana Mehran, George Dangas et al.|Journal of the American College of Cardiology|2024Cited by 0
IMPACT OF DIABETES MELLITUS ON 1-YEAR OUTCOMES OF BIODEGRADABLE VERSUS DURABLE POLYMER DRUG ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOLLOWING ROTATIONAL ATHERECTOMY: RESULTS FROM LARGE PROSPECTIVE REGISTRYRakhee R Makhija, Samin K. Sharma, Matthew Siano et al.|Journal of the American College of Cardiology|2024Cited by 0
SHOULD ADDITIONAL VESSELS BE TREATED DURING LEFT MAIN PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM A LARGE PROSPECTIVE REGISTRYDavid Power, Samin K. Sharma, Anastasios Roumeliotis et al.|Journal of the American College of Cardiology|2024Cited by 0